Angiopoietin-2, permeability oedema, occurrence and severity of ALI/ARDS in septic and non-septic critically ill patients

Thorax

Volumn 63, Issue 10, 2008, Pages 903-909

  Van Der Heijden, M ^a   Van Nieuw Amerongen, G P ^a   Koolwijk, P ^a   Van Hinsbergh, V W M ^a   Groeneveld, A B J ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOPOIETIN 1; ANGIOPOIETIN 2; TRANSFERRIN GA 67; VASCULOTROPIN; VON WILLEBRAND FACTOR;

ACUTE LUNG INJURY; ACUTE RESPIRATORY TRACT DISEASE; ARTICLE; ARTIFICIAL VENTILATION; CONTROLLED STUDY; CRITICAL ILLNESS; DISEASE SEVERITY; DYE DILUTION CURVE; HUMAN; LUNG EDEMA; LUNG EXTRAVASCULAR FLUID; LUNG FUNCTION; LUNG INJURY SCORE; LUNG PERMEABILITY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RECEIVER OPERATING CHARACTERISTIC; SCORING SYSTEM; SEPSIS;

EID: 53649099512     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thx.2007.087387     Document Type: Article

References (34)

1. Hudson LD, Milberg JA, Anardi D, et al. Clinical risks for development of the acute respiratory distress syndrome. Am J Respir Crit Care Med 1995;151:293-301.
2. Parikh SM, Mammoto T. Schultz A, et al. Excess circulating angiopoietin-2 may contribute to pulmonary vascular leak in sepsis in humans. PLoS Med 2006;3:e46.
3. Mammoto T, Parikh SM. Mammoto A. et al. Angiopoietin-1 requires P190RhoGAP to protect against vascular leakage in vivo. J Biol Chem 2007;282:23910-8.
4. Orfanos SE, Kotanidou A, Glynos C, et al. Angiopoietin-2 is increased in severe sepsis: correlation with inflammatory mediators. Crit Can Med 2006;35:199-206.
5. Giuliano Jr JS, Lahni PM. Harmon K. et al. Admission angiopoietin levels in children with septic shock. Shock 2007;28:650-4.
6. Gallangher DC, Parikh SM, Balonov K, et al. Circulating angiopoietin 2 correlates with mortality in a surgical population with acute lung injury/adult respiratory distress syndrome. Shock 2007. Published Online First: 13 December 2007. doi: 10.1097/shk.0b013e31815dd92f.
7. Roviezzo F, Tsigkos S. Kotanidou A, et al. Angiopoietin-2 causes inflammation in vivo by promoting vascular leakage. J Pharmacol Exp ther 2005;314:738-44.
8. Thurston G, Rudge JS. Ioffe E, et al. Angiopoietin-1 protects the adult vasculature against plasma leakage. Nat Med 2000;6:460-3.
9. Wetzerbichler B, Westermann D, Knueppel S, et al. Protective role of angiopoietin-1 in endotoxic shock. Circulation 2005;111:97-105.
10. Bhandari V, Choo-Wing R, Lee CG, et al. Hyperoxia causes angiopoietin 2-mediated acute lung injury and necrotic cell death. Nat Med 2006;12:1286-93.
11. Eklund L, Olsen BR. Tie receptors and their angiopoietin ligands are contextdependent regulators of vascular remodelling. Exp Cell Res 2006;312:630-41.
12. Yano K, Liaw PC. Mullington JM, et al. Vascular endothelial growth factor is an important determinant of sepsis morbidity and mortality. J Exp Med 2006;203:1447-58.
13. Thickett DR, Armstrong L. Christie SJ, et al. Vascular endothelial growth factor may contribute to increased vascular permeability in acute respiratory distress syndrome. Am J Respir Crit Care Med 2001;164:1601-5.
14. Pickkers P, Sprang T. Eijk L, et al. Vascular endothelial growth factor is increased during the first 48 hours of human septic shock and correlates with vascular permeability. Shock 2005;24:508-12.
15. Van dor Her M, van Leeuwen HJ. van Kessel KP, et al. Plasma vascular endothelial growth factor in severe sepsis. Shock 2005;23:35-8.
16. Fiedler U, Scharpfenecker M. Koidl S, et al. The Tie-2 ligand angiopoietin-2 is stored in and rapidly released upon stimulation from endothelial cell Weibel-Palade bodies. Blood 2004;103:4150-6.
17. Wong MP, Chan SY, Fu KH, et al. The angiopoietins, tie2 and vascular endothelial growth factor are differentially expressed in the transformation of normal lung to nonsmall cell lung carcinomas. Lung Cancer 2000;29:11-22.
18. Gamble JR, Drew J. Trezise L, et al. Angiopoietin-1 is an antipermeability and antiinflammatory agent in vitro and targets cell junctions. Circ Res 2000;87:603-7.
19. Jho D, Mehta D. Ahmmed G, et al. Angiopoietin-1 opposes VEGF-induced increase in endothelial permeability by inhibiting TRPC1-dependent Ca2 influx. Circ Res 2005;96:1282-90.
20. Kim I. Moon SO, Park SK. et al. Angiopoietin-1 reduces VEGF-stimulated leukocyte adhesion to endothelial cells by reducing ICAM-1. VCAM-1. and E-selectin expression. Circ Res 2001;89:477-9.
21. Scharpfaneckar M, Fiedler U, Reiss Y, et al. The Tie-2 ligand angiopoietin-2 destabilizes quiescent endothelium through an internal autocnne loop mechanism. J Cell Sci 2005;118:771-80.
22. Daly C, Pasnikowski E, Burova E, et al. Angiopoietin-2 functions as an autocnne protective factor in stressed endothelial cells. Proc Natt Acad Sci USA 2006;103:15491-6.
23. Fiedler U, Reiss Y, Scharpfenecker M, et al. Angiopoietin-2 sensitizes endothelial cells to TNF-alpha and has a crucial role in the induction of inflammation. Nat Med 2006;12:235-9.
24. Ware LB, Conner ER, Matthay MA. von Willebrand factor antigen is an independent marker of poor outcome in patients with early acute lung injury. Crit Care Med 2001;29:2325-31.
25. Ware LB, Eisner MD, Thompson T, et al. Significance of von Willebrand factor in septic and nonseptic patients with acute lung injury. Am J Respir Crit Care Med 2004;170:766-72.
26. Groeneveld AB, Raijmakers PG, Teule GJ, et al. The 67gallium pulmonary leak index in assessing the severity and course of the adult respiratory distress syndrome. Crit Care Med 1996;24:1467-72.
27. Sinclair DG, Braude S, Haslam PL, et al. Pulmonary endothelial injury in patients with severe lung injury. Clinical correlates and natural history. Chest 1994;106:535-9.
28. Verheij J, van Lingen A, Raijmakers PG, et al. Effect of fluid loading with saline or colloids on pulmonary permeability, oedema and lung injury score after cardiac and major vascular surgery. Br J Anaesth 2006;96:21-30.
29. Groeneveld AB, Verheij J. Extravascular lung water to blood volume ratios as measures of permeability in sepsis-induced ALI/ARDS. Intensive Care Med 2006;32:1315-21.
30. Gödje O, Peyerl M, Seebauer T, et al. Reproducibility of double indicator dilution measurements of intrathoracic blood volume compartments, extravascular lung water, and liver function. Chest 1998;113:1070-7.
31. Michard F. Bedside assessment of extravascular lung water by dilution methods: Temptations and pitfalls. Crit Care Med 2007;35:1186-92.
32. Bernard GR, Artigas A, Brigham KL, et al. Report of the American-European consensus conference on ARDS: definitions, mechanisms, relevant outcomes and clinical trail coordination. The Consensus Committee. Intensive Care Med 1994;20:225-32.
33. Murray JF, Matthay MA, Luce JM, et al. An expanded definition of the adult respiratory distress syndrome. Am Rev Hespir Dis 1988;138:720-23.
34. Van de Visse EP, Van der Heijden M, Verheij J, et al. Effect of prior statin therapy on capillary permeability in the lungs after cardiac or vascular surgery. Eur Hespir J 2006;27:1026-32.